Literature DB >> 2419299

Enoxacin concentration in human prostatic tissue after oral administration.

S Rannikko, A S Malmborg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2419299     DOI： 10.1093/jac/17.1.123

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

Review 1.  Role of quinolones in surgical prophylaxis.

Authors:  L A Mandell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 2.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 3.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

4.  [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].

Authors:  K G Naber; F Sörgel; F Kees; H Schumacher; G Sigl; J Zürcher; S Berger
Journal:  Infection       Date:  1989       Impact factor: 3.553

Review 5.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of the newer antibacterial 4-quinolones.

Authors:  M Neuman
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

Review 7.  Tissue penetration and clinical efficacy of enoxacin in urinary tract infections.

Authors:  S J Childs
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 8.  Clinical overview of enoxacin.

Authors:  S H Zinner
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.